This archive contains the following articles listed by volume, issue and page number:
 |
|
|
| Volume 14, 2010 Articles |
| Title (Click for Details) |
Vol/Issue |
Page |
| PreScription: APhA and IJPC Working Together |
Vol. 14 No. 1 |
4 |
| PreScription: American Pharmacists Assocation and Compounding: New Partnership Reflects Old Ties |
Vol. 14 No. 1 |
4 |
| When Traditional Medicine Fails |
Vol. 14 No. 1 |
6 |
| Sleepless in America: Compounding with Melatonin |
Vol. 14 No. 1 |
10 |
| Prophylaxis Against Exposure to Bloodborne Pathogens During Compounding |
Vol. 14 No. 1 |
14 |
| Compounding Pharmacy: A Unique Service for a Unique Population |
Vol. 14 No. 1 |
19 |
| Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet |
Vol. 14 No. 1 |
21 |
| Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging |
Vol. 14 No. 1 |
26 |
| Unit Dose Packaging and Repackaging of Solid and Liquid Dosage Forms in an Institutional Setting |
Vol. 14 No. 1 |
32 |
| Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis |
Vol. 14 No. 1 |
40 |
| An Academic Practice Partnership: An Innovative Course in Advanced Compounding |
Vol. 14 No. 1 |
48 |
| Literature Review & Importance of Quality Control |
Vol. 14 No. 1 |
54 |
| Calculations |
Vol. 14 No. 1 |
58 |
| Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control |
Vol. 14 No. 1 |
60 |
| Hand Sanitizer Gel |
Vol. 14 No. 1 |
66 |
| Hydrocarbon-Free Lotion |
Vol. 14 No. 1 |
67 |
| Ketoprofen 100-mg/5-mL Mouth Rinse |
Vol. 14 No. 1 |
68 |
| Metronidazole in Normal Saline Enema |
Vol. 14 No. 1 |
69 |
| Ophthalmic Toning-Lubricating Drops |
Vol. 14 No. 1 |
70 |
| Solprotex 2.5% Lotion |
Vol. 14 No. 1 |
71 |
| Testosterone 1% in Alcoholic Gel |
Vol. 14 No. 1 |
72 |
| Tetracaine 4% and Menthol 5% Topical Gel |
Vol. 14 No. 1 |
73 |
| Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution |
Vol. 14 No. 1 |
74 |
| Trigger Point Gel |
Vol. 14 No. 1 |
75 |
| Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle |
Vol. 14 No. 1 |
76 |
| Evaluation of a Simple Method for Visual Detection of Microprecipitates in Blends of Parenteral Drug Solutions Using a Focussed (Tyndall) Light Beam |
Vol. 14 No. 1 |
78 |
| Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) |
Vol. 14 No. 1 |
82 |
| Postscription: 2010 A New Year, New Commitments, and New Challenges |
Vol. 14 No. 1 |
86 |
| PreScription: The Ages of Man |
Vol. 14 No. 2 |
92 |
| PreScription: Changing the Game |
Vol. 14 No. 2 |
92 |
| Emerging Evidence for Androgen Replacement Therapy in Aging Men |
Vol. 14 No. 2 |
94 |
| Hormonal Influences in Prostate Cancer: An Update of a Complex Subject |
Vol. 14 No. 2 |
100 |
| Determining the Causes of Erectile Dysfunction: Can Medications Be a Double-Sided Sword? |
Vol. 14 No. 2 |
105 |
| Coenzyme Q10 Supplementation in the Treatment of Heart Disease |
Vol. 14 No. 2 |
108 |
| Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient |
Vol. 14 No. 2 |
112 |
| Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules |
Vol. 14 No. 2 |
118 |
| Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes |
Vol. 14 No. 2 |
124 |
| Cop's Best Friend: Preventing the Illegal Distribution and Transportation of Prescription Drugs |
Vol. 14 No. 2 |
131 |
| Owning an In-Network Pharmacy and a Second Out-of-Network Pharmacy that Performs Compounding: Suggestions on How to Avoid Being Terminated from the Pharmacy Benefits Manager Network |
Vol. 14 No. 2 |
134 |
| Quality Control: From Record Keeping to Key Performance Indicators: Managing Quality in Compounding Pharmacies |
Vol. 14 No. 2 |
136 |
| Calculations |
Vol. 14 No. 2 |
140 |
| Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests |
Vol. 14 No. 2 |
142 |
| Acyclovir 5% in Oral Adhesive Paste |
Vol. 14 No. 2 |
150 |
| Acyclovir 200-mg/5-mL Oral Suspension (From the Injection) |
Vol. 14 No. 2 |
151 |
| Ciclopirox 10% in Isopropyl Alcohol Nail Solution |
Vol. 14 No. 2 |
152 |
| Clotrimazole 1% Oral Adhesive Paste |
Vol. 14 No. 2 |
153 |
| Cyclosporin 10-mg/g in Oral Adhesive Paste |
Vol. 14 No. 2 |
154 |
| Dexpanthenol 5% Gel-Cream |
Vol. 14 No. 2 |
155 |
| Lamotrigine 25-mg/mL Injection |
Vol. 14 No. 2 |
156 |
| Metolazone 10-mg/mL Injection |
Vol. 14 No. 2 |
157 |
| Plasticized Hydrocarbon Gel |
Vol. 14 No. 2 |
158 |
| Oral Adhesive Paste |
Vol. 14 No. 2 |
159 |
| Chemical Stability of Hydromorphone Hydrochloride in Patient-Controlled Analgesia Injector |
Vol. 14 No. 2 |
160 |
| Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study |
Vol. 14 No. 2 |
165 |
| Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders |
Vol. 14 No. 2 |
171 |
| PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort? |
Vol. 14 No. 2 |
174 |
| PreScription: Quality Improvement in Pharmaceutical Compounding |
Vol. 14 No. 3 |
180 |
| PreScription: Healthcare Reform Is Not All That Is Happening in Washington |
Vol. 14 No. 3 |
180 |
| Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome |
Vol. 14 No. 3 |
182 |
| The Role of Sex Hormones on Fibromyalgia Pain Mediators |
Vol. 14 No. 3 |
193 |
| Topical Medications for Orofacial Neuropathic Pain |
Vol. 14 No. 3 |
200 |
| Managing Pain with Transdermal Ketoprofen |
Vol. 14 No. 3 |
204 |
| Potential Treatments for Radiation Dermatitis |
Vol. 14 No. 3 |
210 |
| Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report |
Vol. 14 No. 3 |
215 |
| Quality Control Analytical Methods: Continuous Quality Improvement |
Vol. 14 No. 3 |
218 |
| Basics of Compounding: Compounding with Hydrates and Solvates |
Vol. 14 No. 3 |
222 |
| Calculations |
Vol. 14 No. 3 |
230 |
| Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations |
Vol. 14 No. 3 |
232 |
| Bacitracin 10,000-Units/mL Ophthalmic Solution |
Vol. 14 No. 3 |
240 |
| Carprofen 2.5-mg/mL Oral Suspension, Veterinary |
Vol. 14 No. 3 |
241 |
| Celecoxib 10-mg/mL Oral Suspension |
Vol. 14 No. 3 |
242 |
| Clozapine 20-mg/mL Oral Suspension |
Vol. 14 No. 3 |
243 |
| Cohen's Rectal Ointment |
Vol. 14 No. 3 |
244 |
| Cyclophosphamide 10-mg/mL Oral Suspension |
Vol. 14 No. 3 |
245 |
| Lansoprazole 3-mg/mL Oral Suspension |
Vol. 14 No. 3 |
246 |
| Rifaximin 20-mg/mL Oral Suspension |
Vol. 14 No. 3 |
247 |
| Sunitinib 10-mg/mL Oral Suspension |
Vol. 14 No. 3 |
248 |
| Voriconazole 40-mg/mL Oral Suspension, Veterinary |
Vol. 14 No. 3 |
249 |
| Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration |
Vol. 14 No. 3 |
250 |
| Weight Uniformity of Scored Tablet Halves Manufactured by Palestinian Pharmaceutical Companies |
Vol. 14 No. 3 |
257 |
| PostScription: Healthcare Reform and Compounding Issues |
Vol. 14 No. 3 |
262 |
| PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle |
Vol. 14 No. 4 |
268 |
| PreScription: Sterile Product Outsourcing: Growing Trend in Hospitals |
Vol. 14 No. 4 |
268 |
| Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together |
Vol. 14 No. 4 |
270 |
| Recommendations for Compounding Medications for Feeding Tube Administration |
Vol. 14 No. 4 |
276 |
| Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents |
Vol. 14 No. 4 |
284 |
| Considerations for Percutaneous Absorption |
Vol. 14 No. 4 |
301 |
| Thyroid Potency Calculations |
Vol. 14 No. 4 |
306 |
| Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser |
Vol. 14 No. 4 |
310 |
| Quality Control Analytical Methods: Pharmacopeial Bacterial Endotoxins Test Chapters |
Vol. 14 No. 4 |
317 |
| Basics of Compounding: Basics of Compounding with Organic Salts |
Vol. 14 No. 4 |
322 |
| Calculations |
Vol. 14 No. 4 |
327 |
| Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program |
Vol. 14 No. 4 |
328 |
| Acyclovir with Benzocaine Lip Balm |
Vol. 14 No. 4 |
332 |
| Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone |
Vol. 14 No. 4 |
333 |
| Amitriptyline Hydrochloride Suppositories |
Vol. 14 No. 4 |
334 |
| Ampicillin 250-mg Suppository |
Vol. 14 No. 4 |
335 |
| Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops |
Vol. 14 No. 4 |
336 |
| Buprenorphine Hydrochloride Injection |
Vol. 14 No. 4 |
337 |
| Chloroprocaine Hydrochloride Injection |
Vol. 14 No. 4 |
338 |
| Cyanocobalamin, Choline, and Niacinamide Injection |
Vol. 14 No. 4 |
339 |
| Fenoldopam Mesylate Injection |
Vol. 14 No. 4 |
340 |
| Flurbiprofen 5% Bioadhesive Gel for Gingivitis |
Vol. 14 No. 4 |
341 |
| Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping |
Vol. 14 No. 4 |
342 |
| Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin |
Vol. 14 No. 4 |
346 |
| PostScription: Innovative Community Pharmacy Practice: Past, Present, and Future |
Vol. 14 No. 4 |
350 |
| PreScription: Revised Format |
Vol. 14 No. 5 |
358 |
| PreScription: Compounding Veterinary Products: Needed but Problematic |
Vol. 14 No. 5 |
358 |
| Home Infusion Accreditation: Another Quality Recognition Branding Tool |
Vol. 14 No. 5 |
360 |
| Community Pharmacy Addresses the Need for Proper Drug Disposal with Positive Response |
Vol. 14 No. 5 |
366 |
| Implementation of a Viable Air-Sampling Program Using a Volumetric Collection Device |
Vol. 14 No. 5 |
370 |
| Bioidentical Hormones in the News |
Vol. 14 No. 5 |
374 |
| Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists |
Vol. 14 No. 5 |
382 |
| Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients |
Vol. 14 No. 5 |
395 |
| Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 1 |
Vol. 14 No. 5 |
401 |
| Quality Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 1 |
Vol. 14 No. 5 |
407 |
| Basics of Compounding: Basics of Compounding with Esters |
Vol. 14 No. 5 |
416 |
| Calculations |
Vol. 14 No. 5 |
419 |
| Alpha-Bisabolol Mouthwash |
Vol. 14 No. 5 |
420 |
| Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution |
Vol. 14 No. 5 |
421 |
| Icy Blue Camphorated Gel |
Vol. 14 No. 5 |
422 |
| Carvedilol 1-mg/mL Oral Suspension |
Vol. 14 No. 5 |
423 |
| Buspirone 2.5-mg/mL Oral Suspension |
Vol. 14 No. 5 |
424 |
| Triclosan 0.28% Mouthwash |
Vol. 14 No. 5 |
425 |
| Rufinamide 40-mg/mL Oral Suspension |
Vol. 14 No. 5 |
426 |
| Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection |
Vol. 14 No. 5 |
427 |
| Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection |
Vol. 14 No. 5 |
428 |
| Polidocanol 0.5% Wound Spray |
Vol. 14 No. 5 |
429 |
| Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study |
Vol. 14 No. 5 |
430 |
| Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device |
Vol. 14 No. 5 |
436 |
| PostScription: Guidance to Achieve Accreditation from the Pharmacy Compounding Accreditation Board |
Vol. 14 No. 5 |
440 |
| PreScription: Compounding with Manufactured Products |
Vol. 14 No. 6 |
448 |
| Home Infusion: Overcoming the Barriers to Entry |
Vol. 14 No. 6 |
450 |
| In the Hands of Your Enemy |
Vol. 14 No. 6 |
456 |
| The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women |
Vol. 14 No. 6 |
465 |
| Extemporaneous Compounding of Medicated Ointment |
Vol. 14 No. 6 |
472 |
| "My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care |
Vol. 14 No. 6 |
480 |
| All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding |
Vol. 14 No. 6 |
484 |
| Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin |
Vol. 14 No. 6 |
488 |
| Quality-Control Analytical Methods: Endotoxins: Essential Testing for Pyrogens in the Compounding Laboratory, Part 2 |
Vol. 14 No. 6 |
493 |
| Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates |
Vol. 14 No. 6 |
508 |
| Calculations |
Vol. 14 No. 6 |
511 |
| Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
512 |
| Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
513 |
| Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
514 |
| Bromazepam 2.5-mg/mL Drops |
Vol. 14 No. 6 |
515 |
| Bromhexine Hydrochloride 0.8-mg/mL Syrup |
Vol. 14 No. 6 |
516 |
| Capsaicin 0.05% Clear Medication Stick |
Vol. 14 No. 6 |
517 |
| Glutathione 25% in Pluronic Lecithin Organogel |
Vol. 14 No. 6 |
518 |
| Gramicidin 13% Ophthalmic Solution |
Vol. 14 No. 6 |
519 |
| Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel |
Vol. 14 No. 6 |
520 |
| Ketoprofen 2% Oral Gel |
Vol. 14 No. 6 |
521 |
| Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date |
Vol. 14 No. 6 |
522 |
| Barrier Isolator/Glovebox Glove Dexterity Study |
Vol. 14 No. 6 |
526 |
| PostScription: Profile of a Pharmacy Compounding Accreditation Board Accredited Pharmacy: Avera Doctors Plaza 2 Pharmacy |
Vol. 14 No. 6 |
531 |
